Hepatitis B vaccine recombinant - Sanofi
Alternative Names: SHANVAC-BLatest Information Update: 31 Mar 2022
At a glance
- Originator Shantha Biotechnics
- Developer Sanofi
- Class DNA vaccines; Hepatitis B vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hepatitis B